69.51
price up icon1.00%   0.69
 
loading
Dexcom Inc stock is traded at $69.51, with a volume of 2.60M. It is up +1.00% in the last 24 hours and down -2.13% over the past month. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$68.82
Open:
$68.97
24h Volume:
2.60M
Relative Volume:
0.52
Market Cap:
$27.64B
Revenue:
$3.93B
Net Income/Loss:
$666.90M
P/E Ratio:
76.38
EPS:
0.91
Net Cash Flow:
$665.50M
1W Performance:
+1.31%
1M Performance:
-2.13%
6M Performance:
-47.21%
1Y Performance:
-33.94%
1-Day Range:
Value
$68.14
$69.90
1-Week Range:
Value
$66.86
$71.56
52-Week Range:
Value
$62.34
$142.00

Dexcom Inc Stock (DXCM) Company Profile

Name
Name
Dexcom Inc
Name
Phone
(858) 200-0200
Name
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Employee
9,600
Name
Twitter
@dexcom
Name
Next Earnings Date
2024-07-25
Name
Latest SEC Filings
Name
DXCM's Discussions on Twitter

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Date Action Analyst Rating Change
May-30-23 Resumed Morgan Stanley Equal-Weight
Apr-17-23 Upgrade Raymond James Outperform → Strong Buy
Mar-29-23 Initiated UBS Buy
Jan-26-23 Initiated Wolfe Research Outperform
Oct-18-22 Initiated Barclays Equal Weight
Oct-12-22 Initiated Jefferies Buy
Jul-15-22 Initiated Bernstein Outperform
Mar-02-22 Resumed BofA Securities Buy
Feb-03-22 Upgrade BTIG Research Neutral → Buy
Jan-19-22 Upgrade Wells Fargo Equal Weight → Overweight
Jan-07-22 Upgrade Guggenheim Neutral → Buy
Oct-18-21 Downgrade Guggenheim Buy → Neutral
Jul-21-21 Resumed Cowen Outperform
May-28-21 Upgrade Wells Fargo Underweight → Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Jan-06-21 Upgrade UBS Neutral → Buy
Oct-02-20 Downgrade Wells Fargo Equal Weight → Underweight
May-27-20 Reiterated Piper Sandler Overweight
May-14-20 Initiated Wells Fargo Equal Weight
Mar-05-20 Initiated Citigroup Buy
Nov-07-19 Reiterated Canaccord Genuity Buy
Nov-07-19 Upgrade Guggenheim Neutral → Buy
Oct-23-19 Initiated Stifel Buy
Nov-28-18 Initiated UBS Neutral
Oct-19-18 Upgrade Goldman Sell → Neutral
Sep-12-18 Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18 Reiterated Canaccord Genuity Buy
Jul-02-18 Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18 Upgrade JP Morgan Neutral → Overweight
May-11-18 Initiated BofA/Merrill Buy
May-03-18 Reiterated Canaccord Genuity Buy
Apr-04-18 Initiated Goldman Sell
Apr-04-18 Initiated Guggenheim Neutral
Mar-23-18 Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18 Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17 Reiterated Wedbush Outperform
View All

Dexcom Inc Stock (DXCM) Latest News

pulisher
06:36 AM

DXCM STOCK ALERT: DexCom, Inc. Investors are Notified of Imminent October 21 Deadline in Class Action; Inform BFA Law if you Incurred Losses (Nasdaq:DXCM) - GlobeNewswire Inc.

06:36 AM
pulisher
Sep 14, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Sep 14, 2024
pulisher
Sep 14, 2024

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - PR Newswire

Sep 14, 2024
pulisher
Sep 14, 2024

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Kilgore News Herald

Sep 14, 2024
pulisher
Sep 14, 2024

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200 - The Motley Fool

Sep 14, 2024
pulisher
Sep 13, 2024

DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. - Markets Insider

Sep 13, 2024
pulisher
Sep 13, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM - ForexTV.com

Sep 13, 2024
pulisher
Sep 13, 2024

DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 13, 2024
pulisher
Sep 13, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM - GlobeNewswire Inc.

Sep 13, 2024
pulisher
Sep 13, 2024

DXCM STOCK ALERT: A Class Action is Pending Against DexCom, Inc. for Securities Fraud; Contact BFA Law before October 21 Court Deadline if You Lost Money - AccessWire

Sep 13, 2024
pulisher
Sep 13, 2024

Faruqi & Faruqi Reminds DexCom Investors of the Pending - GlobeNewswire

Sep 13, 2024
pulisher
Sep 13, 2024

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Sep 13, 2024
pulisher
Sep 13, 2024

Is DexCom Stock Underperforming The S&P 500? - Barchart

Sep 13, 2024
pulisher
Sep 13, 2024

DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Sep 13, 2024
pulisher
Sep 13, 2024

Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact Levi & Korsinsky - AccessWire

Sep 13, 2024
pulisher
Sep 13, 2024

DXCM INVESTOR DEADLINE: DexCom, Inc. Investors that Lost - GlobeNewswire

Sep 13, 2024
pulisher
Sep 13, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. LawsuitDXCM - PR Newswire

Sep 13, 2024
pulisher
Sep 12, 2024

DexCom (DXCM) Sales Force Changes Drove Poor Execution, Disappointing Outlook, & 40% Stock Drop, Class Action Pending – Hagens Berman - ForexTV.com

Sep 12, 2024
pulisher
Sep 12, 2024

mHealth Market Next Big Thing | Major Giants- Fitbit, DEXCOM, Boston Scientific - Newstrail

Sep 12, 2024
pulisher
Sep 12, 2024

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsDXCM - AccessWire

Sep 12, 2024
pulisher
Sep 12, 2024

DexCom Inc. stock rises Thursday, still underperforms market - MarketWatch

Sep 12, 2024
pulisher
Sep 12, 2024

Wall Street Analyst Downgrade Dexcom Inc [DXCM]. What else is Wall St. saying - The DBT News

Sep 12, 2024
pulisher
Sep 12, 2024

DexCom (DXCM) Sales Force Changes Drove Poor Execution, - GlobeNewswire

Sep 12, 2024
pulisher
Sep 12, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom - The Malaysian Reserve

Sep 12, 2024
pulisher
Sep 12, 2024

Dexcom data: CGM for type 2 diabetes without insulin treatment - BioWorld Online

Sep 12, 2024
pulisher
Sep 12, 2024

Prudential PLC Boosts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - Defense World

Sep 12, 2024
pulisher
Sep 12, 2024

A stock that deserves closer examination: Dexcom Inc (DXCM) - US Post News

Sep 12, 2024
pulisher
Sep 12, 2024

3 Reasons DexCom Looks Like a No-Brainer Buy Right Now - The Motley Fool

Sep 12, 2024
pulisher
Sep 12, 2024

Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - AccessWire

Sep 12, 2024
pulisher
Sep 12, 2024

DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Sep 12, 2024
pulisher
Sep 12, 2024

Dexcom COO sells shares worth over $51,000 By Investing.com - Investing.com Australia

Sep 12, 2024
pulisher
Sep 12, 2024

Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Sep 12, 2024
pulisher
Sep 11, 2024

Insider Selling: DexCom, Inc. (NASDAQ:DXCM) EVP Sells 426 Shares of Stock - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom COO sells shares worth over $51,000 - Investing.com India

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom CFO sells shares worth over $51k - Investing.com India

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom executive sells over $29k in company stock - Investing.com India

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom executive sells over $29k in company stock - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch

Sep 11, 2024
pulisher
Sep 11, 2024

DXCM INVESTOR ALERT: If You Suffered Losses on Your DexCom, Inc. Investment, Contact BFA Law Before Upcoming October 21 Class Action Deadline - AccessWire

Sep 11, 2024
pulisher
Sep 11, 2024

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - GlobeNewswire Inc.

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom Inc [DXCM] stock was sold by Brown Michael Jon at the price of US$48020.0 - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

Dexcom, Abbott OTC glucose sensors add to busy year for diabetes tech - MedTech Dive

Sep 11, 2024
pulisher
Sep 11, 2024

Class Action Filed Against DexCom, Inc. (DXCM)October 21, 2024 Deadline to JoinContact Levi & Korsinsky - AccessWire

Sep 11, 2024
pulisher
Sep 11, 2024

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Sep 11, 2024
pulisher
Sep 11, 2024

Daiwa Securities Group Inc. Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc.DXCM - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 11, 2024

DexCom, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsDXCM - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 11, 2024

Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 10, 2024

DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM - AccessWire

Sep 10, 2024
pulisher
Sep 10, 2024

From Hero To Zero: DexCom's Big Fall And What's Next (NASDAQ:DXCM) - Seeking Alpha

Sep 10, 2024
pulisher
Sep 10, 2024

DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: - GlobeNewswire

Sep 10, 2024

Dexcom Inc Stock (DXCM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Dexcom Inc Stock (DXCM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Sylvain Jereme M
EVP, Chief Financal Officer
Sep 09 '24
Sale
69.15
746
51,586
84,274
Leach Jacob Steven
EVP, Chief Operating Officer
Sep 09 '24
Sale
69.15
746
51,586
264,915
Brown Michael Jon
EVP, Chief Legal Officer
Aug 30 '24
Sale
70.00
686
48,020
65,636
medical_devices PHG
$30.74
price down icon 0.07%
medical_devices STE
$244.83
price down icon 0.67%
medical_devices ZBH
$106.26
price up icon 1.07%
$86.91
price down icon 0.63%
medical_devices EW
$68.52
price up icon 0.57%
Cap:     |  Volume (24h):